In another study on AD patients, METTL3 expression was downregulated and RBM15B expression was upregulated in the hippocampus, while METTL3 was significantly accumulated in insoluble tau protein, suggesting a correlation between METTL3 and tau protein deposition [59]. The gene discussed is MAPT; the disease is Alzheimer disease.